Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles.

Sequence variation displayed by the human immunodeficiency virus type 1 (HIV-1) has been proposed to be linked to the pathogenesis of acquired immunodeficiency syndrome (AIDS). To assess viral evolution during the course of infection, we evaluated sequence variability in the env variable domains in four HIV-1-infected individuals exhibiting differing profiles of CD4+ T cell decline when followed from seroconversion until the development of AIDS or loss of followup. Proviral sequences encoding the V3-V5 region of gp 120 were obtained following PCR amplification of peripheral blood mononuclear cell DNA and cloning. Virus in each patient was relatively homogeneous early in infection and then diverged with time, more consistently at its nonsynonymous sites. Just prior to or coincident with a rapid decline in CD4+ T cell numbers, sequences were found with basic amino acid substitutions clustered within and downstream of the gp 120 V3 domain. Within the constraints of the current data set, we conclude that the virus appears to continually accumulate changes in its amino acid sequences well into the time of marked CD4+ T cell decline.

[1]  C. Kuiken,et al.  Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. , 1991, Virology.

[2]  A. Perelson,et al.  HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.

[3]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[4]  J. S. Sullivan,et al.  Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.

[5]  Huisman,et al.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.

[6]  D. Shriner,et al.  Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses , 1997, Journal of virology.

[7]  G. Ehrlich Caveats of PCR , 1991 .

[8]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[9]  C. Rinaldo,et al.  High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.

[10]  L. Kingsley,et al.  Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals , 1995, Journal of virology.

[11]  J. Mullins,et al.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14 , 1990, Nature.

[12]  D. Ho,et al.  Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression , 1994, Journal of virology.

[13]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[14]  A. Rodrigo,et al.  Human immunodeficiency virus type 1 molecular evolution and the measure of selection. , 1996, AIDS research and human retroviruses.

[15]  M A Nowak,et al.  Antigenic diversity thresholds and the development of AIDS. , 1991, Science.

[16]  E. G. Shpaer,et al.  Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual , 1995, Journal of virology.

[17]  B. Korber,et al.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. , 1992, Science.

[18]  T Gojobori,et al.  Molecular clock of viral evolution, and the neutral theory. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Sudhir Kumar,et al.  MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers , 1994, Comput. Appl. Biosci..

[20]  Lange,et al.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.

[21]  S. Müller,et al.  Deceptive imprinting in the immune response against HIV-1. , 1994, Immunology today.

[22]  R. Redfield,et al.  Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns , 1991, Journal of virology.

[23]  C. Kuiken,et al.  Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period , 1995, Journal of virology.

[24]  L. P. Zhao,et al.  HIV Quasispecies and Resampling , 1996, Science.

[25]  B. Margolin,et al.  V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability , 1993, Journal of virology.

[26]  T. Kunkel,et al.  DNA polymerase fidelity and the polymerase chain reaction. , 1991, PCR methods and applications.

[27]  G. Learn,et al.  Maintaining the integrity of human immunodeficiency virus sequence databases , 1996, Journal of virology.

[28]  J. Goudsmit,et al.  HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. , 1992, Virology.

[29]  J. Mullins,et al.  Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome. , 1991, Journal of acquired immune deficiency syndromes.

[30]  G. Ehrlich,et al.  39 – DETECTION OF HUMAN T-CELL LYMPHOMA/LEUKEMIA VIRUSES , 1990 .

[31]  J. Goudsmit,et al.  Clonal dominance: cause for a limited and failing immune response to HIV-1 infection and vaccination. , 1992, Journal of acquired immune deficiency syndromes.

[32]  A. Saah,et al.  Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Walker,et al.  Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays , 1994, Journal of virology.

[34]  D. Baltimore,et al.  Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Ho,et al.  Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals , 1993, Journal of virology.

[36]  D. Lipman,et al.  Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[38]  N. Haigwood,et al.  V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Johnson,et al.  SIV adaption to human cells , 1989, Nature.

[40]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .

[41]  Martin A. Nowak,et al.  Causes of HIV diversity , 1995, Nature.

[42]  H. Schuitemaker,et al.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population , 1992, Journal of virology.

[43]  G. Ehrlich,et al.  Pcr-Based Diagnostics in Infectious Disease , 1994 .

[44]  R. Siliciano,et al.  Viral Dynamics in HIV-1 Infection , 1998, Cell.

[45]  Xiping Wei,et al.  Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.

[46]  D. Ho,et al.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection. , 1993, Science.

[47]  M. Nei,et al.  The neighbor-joining method , 1987 .

[48]  E. Holmes,et al.  Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection , 1993, Journal of virology.

[49]  H. Schuitemaker,et al.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.

[50]  Steven M. Wolinsky,et al.  Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.

[51]  B. Korber,et al.  Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease , 1997, Journal of virology.

[52]  T. Waldmann,et al.  Multiple sclerosis, retroviruses, and PCR , 1991, Neurology.

[53]  D. Ho,et al.  Rapid generation of sequence variation during primary HIV‐1 infection , 1992, AIDS.

[54]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.